Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BG Medicine, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R15.htm
EX-32 - EX-32 - BG Medicine, Inc.d398643dex32.htm
EX-10.1 - EX-10.1 - BG Medicine, Inc.d398643dex101.htm
EX-31.2 - EX-31.2 - BG Medicine, Inc.d398643dex312.htm
EX-10.2 - EX-10.2 - BG Medicine, Inc.d398643dex102.htm
10-Q - FORM 10-Q - BG Medicine, Inc.d398643d10q.htm
XML - IDEA: XBRL DOCUMENT - BG Medicine, Inc.R3.htm
EX-31.1 - EX-31.1 - BG Medicine, Inc.d398643dex311.htm
v2.4.0.6
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2012
Fair Value of Financial Instruments [Abstract]  
Assets and liabilities measured at fair value on a recurring basis

The following table represents information about the assets and liabilities measured at fair value on a recurring basis as of September 30, 2012 and December 31, 2011:

 

                                 

Description

  Level 1     Level 2     Level 3     Total  
    (in thousands)  

September 30, 2012

       

Liabilities:

                               

Warrant liability

  $ —       $ —       $ 10     $ 10  
         

December 31, 2011

                               

Assets:

                               

Cash equivalents, including restricted cash

  $ 24,045     $ —       $ —       $ 24,045  
         

Liabilities:

                               

Warrant liability

  $ —       $ —       $ 15     $ 15  
Fair value of the common stock warrants determined under Black-Scholes option pricing method

The fair value of the common stock warrants at September 30, 2012 and December 31, 2011 was determined using the Black-Scholes option pricing method. The assumptions included in the Black-Scholes model were as follows:

 

         
    Common Stock
Warrant Liability
    September 30, 2012   December 31, 2011

Weighted-average risk-free interest rate

  0.55%   0.90%

Expected dividend yield

  0%   0%

Weighted-average remaining contractual term

  4.5 years   5.3 years

Expected volatility

  74% - 75%   70%

Fair value of underlying shares of stock

  $3.68   $4.72
Fair value of the warrant liability

The following table provides a roll-forward for the three and nine months ending September 30, 2012 and 2011 of the fair value of the warrant liability categorized with Level 3 inputs:

 

                                 
    Warrant Liability  
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2012     2011     2012     2011  
    (in thousands)  

Balance - Beginning of period

  $ 25     $ 32     $ 15     $ 248  

(Decrease) increase in fair value - recognized in operations as other income (expense)

    (15     (21     (5     35  

Reclassification of warrant liability to additional paid in capital

    —         —         —         (272
   

 

 

   

 

 

   

 

 

   

 

 

 

Balance - End of period

  $ 10     $ 11     $ 10     $ 11